Podcast
Questions and Answers
What is the risk of medication-related osteonecrosis of the jaw (MRONJ) associated with parenteral administration of bisphosphonates?
What is the risk of medication-related osteonecrosis of the jaw (MRONJ) associated with parenteral administration of bisphosphonates?
- 1% to 10% (correct)
- 35% to 40%
- 25% to 30%
- 15% to 20%
What is the most common reason for the prescription of bisphosphonates?
What is the most common reason for the prescription of bisphosphonates?
- Osteoporosis (correct)
- Rheumatoid arthritis
- Osteoarthritis
- Gout
What is the relationship between alendronate (Fosamax) and the incidence of osteonecrosis?
What is the relationship between alendronate (Fosamax) and the incidence of osteonecrosis?
- Alendronate has no impact on the incidence of osteonecrosis
- The relationship is not mentioned in the text
- Alendronate reduces the incidence of osteonecrosis
- Alendronate is related to a higher incidence of osteonecrosis (correct)
What percentage of patients reported pain with bone exposure after bisphosphonate treatment?
What percentage of patients reported pain with bone exposure after bisphosphonate treatment?
What does a CTX value of less than 100 pg/mL represent?
What does a CTX value of less than 100 pg/mL represent?
What did the ADA state about the reliability of CTX testing and drug holidays for predicting and mitigating the risk of BRONJ?
What did the ADA state about the reliability of CTX testing and drug holidays for predicting and mitigating the risk of BRONJ?
According to the American Association of Oral and Maxillofacial Surgeons position paper, when should the clinician consider discontinuing the use of oral bisphosphonates before and after elective invasive dental surgery?
According to the American Association of Oral and Maxillofacial Surgeons position paper, when should the clinician consider discontinuing the use of oral bisphosphonates before and after elective invasive dental surgery?
What does the ADA recommend regarding staging of non-critical dental treatment for patients on bisphosphonates?
What does the ADA recommend regarding staging of non-critical dental treatment for patients on bisphosphonates?
What does the text recommend regarding the initiation of bisphosphonate therapy for patients requiring IV bisphosphonates?
What does the text recommend regarding the initiation of bisphosphonate therapy for patients requiring IV bisphosphonates?
How may MRONJ development be reduced for patients on bisphosphonates?
How may MRONJ development be reduced for patients on bisphosphonates?
